A Safety Study of Combination Treatment With Avonex and Zocor in Relapsing Remitting Multiple Sclerosis

NCT00242268 Phase 3 UNKNOWN

The purpose of this study is to determine if using Avonex in combination with Zocor is a safe and effective therapy for subjects with relapsing remitting multiple sclerosis.

Details

Lead sponsor	Alabama Neurology Associates, PC
Phase	Phase 3
Status	UNKNOWN
Enrolment	30
Start date	2005-10

Conditions

• Relapsing Remitting Multiple Sclerosis

Interventions

• Simvastatin

Primary outcomes

• 1. To evaluate the safety of combining Avonex with Zocor for a period of fourteen months in patients with RRMS
• 2. To evaluate the effect of treatment on MRI, specifically new or enlarging T2 lesions burden

Countries

United States